OnKure Therapeutics (OKUR) Assets (2020 - 2026)

OnKure Therapeutics (OKUR) has reported Assets for 7 consecutive years, with $179.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Assets rose 108.38% year-over-year to $179.4 million; the trailing twelve-month figure through Jun 2026 stood at $179.4 million (up 108.38% YoY), and the FY2025 full-year result was $62.1 million, down 45.94% from the prior year.
• Assets slipped to $179.4 million in Q2 2026 per OKUR's latest filing, from $198.7 million in the prior quarter.
• Across five years, Assets topped out at $198.7 million in Q1 2026 and bottomed at $35.7 million in Q4 2023.
• Historically, Assets has averaged $109.8 million across 5 years, with a median of $104.0 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Assets sank 66.97% in 2023, then soared 221.56% in 2024.
• Over 5 years, Assets stood at $108.2 million in 2022, then tumbled by 66.97% to $35.7 million in 2023, then jumped by 221.56% to $114.9 million in 2024, then tumbled by 45.94% to $62.1 million in 2025, then jumped by 188.73% to $179.4 million in 2026.
• According to Business Quant data, Assets over the past three periods registered $179.4 million, $198.7 million, and $62.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.